WCM Investment Management LLC decreased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 54.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,387 shares of the company's stock after selling 4,079 shares during the quarter. WCM Investment Management LLC's holdings in Clorox were worth $547,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Entropy Technologies LP increased its holdings in shares of Clorox by 86.7% during the fourth quarter. Entropy Technologies LP now owns 12,743 shares of the company's stock valued at $2,070,000 after acquiring an additional 5,918 shares in the last quarter. Empowered Funds LLC increased its holdings in shares of Clorox by 1.7% during the fourth quarter. Empowered Funds LLC now owns 22,174 shares of the company's stock valued at $3,601,000 after acquiring an additional 372 shares in the last quarter. Wilmington Savings Fund Society FSB increased its holdings in shares of Clorox by 6.8% during the fourth quarter. Wilmington Savings Fund Society FSB now owns 11,072 shares of the company's stock valued at $1,798,000 after acquiring an additional 706 shares in the last quarter. Advisors Preferred LLC bought a new stake in shares of Clorox during the fourth quarter valued at approximately $427,000. Finally, Kingsview Wealth Management LLC increased its holdings in shares of Clorox by 3.2% during the fourth quarter. Kingsview Wealth Management LLC now owns 5,643 shares of the company's stock valued at $916,000 after acquiring an additional 177 shares in the last quarter. Institutional investors own 78.53% of the company's stock.
Clorox Stock Performance
Shares of NYSE CLX traded down $2.86 during trading on Friday, reaching $147.91. 1,318,065 shares of the stock traded hands, compared to its average volume of 1,333,562. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The company has a 50-day moving average of $159.55 and a 200-day moving average of $159.13. The stock has a market capitalization of $18.31 billion, a P/E ratio of 40.41, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42.
Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm posted $2.16 EPS. Analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.30%. Clorox's dividend payout ratio is presently 133.33%.
Wall Street Analyst Weigh In
CLX has been the subject of several recent research reports. JPMorgan Chase & Co. upped their price target on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company upped their price target on Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Finally, DA Davidson decreased their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $158.21.
Get Our Latest Stock Report on CLX
About Clorox
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
